Search Results 161-170 of 402 for ★베스트토토안전확인【평생베스트.com】베스트토토검증★

  1. A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia - Mayo Clinic

    ... best. Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  2. Semen Analysis in Chemotherapy - Clinical Trials

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 16-010649. Sponsor Protocol Number: 16-010649. About this study. The purpose of this study is to correlate the ...

  3. Essential Thrombocythemia Clinical Trials - Mayo Clinic Research

    This phase I/IB trial studies the side effects, best dose, and efficacy of azacitidine and erismodegib in treating patients with myeloid malignancies. The ...

  4. Neurology - Clinical trials - Mayo Clinic

    Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to evaluate the side effects and best dose of nivolumab when given ...

  5. A Study to Evaluate Parsaclisib (INCB050465), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine And Prednisone (Par-CHOP) Immunochemotherapy for Patients with Newly Diagnosed High Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

    ... best. Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  6. A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - Mayo Clinic

    ... best. Study phase. 3. During the early phases (phases 1 and 2), researchers ... Note: A documented history of a COPD exacerbation (e.g., medical record ...

  7. Loteprednol (ophthalmic route) - Mayo Clinic

    ... best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines ...

  8. Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors - Mayo Clinic

    ... best. Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  9. A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma - Mayo Clinic

    The purpose of this study is to see if the combination of rituximab and ibrutinib can help people with marginal zone lymphoma who have not received treatment in ...

  10. Publications - Prathibha Varkey, M.B.B.S., M.B.A. - Mayo Clinic

    Using a framework for spread of best practices to implement successful venous thromboembolism prophylaxis throughout a large hospital system. Am J Med Qual ...